Search alternatives:
largest decrease » marked decrease (Expand Search)
values decrease » values increased (Expand Search)
larger decrease » marked decrease (Expand Search)
ct values » _ values (Expand Search), i values (Expand Search)
Showing 41 - 60 results of 130 for search '(( ct values decrease ) OR ( ct ((largest decrease) OR (larger decrease)) ))', query time: 0.48s Refine Results
  1. 41

    Table 5_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

    Published 2025
    “…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
  2. 42

    Supplementary file 1_The role of micro-CT in breast cancer management: a systematic review on the clinical applications of micro-CT in breast cancer and a diagnostic accuracy meta-... by Seyed Mostafa Meshkati Yazd (15198320)

    Published 2025
    “…Micro-computed tomography (micro-CT) has already exhibited clinical value, yielding high-resolution three-dimensional (3D) volumetric images. …”
  3. 43

    Table 1_Impact of different 3D regions of interest on quantifying dynamic lumbar vertebral microstructure in ovariectomized rats—a micro-CT study.doc by Huihui Xu (778437)

    Published 2025
    “…However, whether different ROIs directly affect the results of quantitative micro-CT-based microarchitectural data is still unknown. …”
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49
  10. 50
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55
  16. 56
  17. 57
  18. 58

    Data Sheet 1_Changes in pancreatic levodopa uptake in patients with obesity and new-onset type 2 diabetes: an 18F-FDOPA PET-CT study.docx by Yeongkeun Kwon (3611216)

    Published 2025
    “…</p>Results<p>Pancreatic levodopa uptake increased in obese patients with insulin resistance, whereas it decreased in obese patients with new-onset type 2 diabetes [standardized uptake value (SUV) mean in participants with normal weight, 2.6 ± 0.7; SUV<sub>mean</sub> in patients with obesity, 3.6 ± 0.1; SUV<sub>mean</sub> in patients with obesity and new-onset type 2 diabetes, 2.6 ± 0.1, P = 0.02].…”
  19. 59
  20. 60